Table 2. Changes of SE and AL at the 6-month follow-up in the atropine and control group.
Variables | Control group (n=120 eyes) | Atropine group (n=250 eyes) | Difference | 95%CI | t | P |
SE, D | ||||||
Initial | -1.59±0.94 | -1.64±0.80 | 0.05±0.09 | -0.14 to 0.23 | 0.514 | 0.608 |
After 6mo | -2.19±0.92 | -1.91±0.87 | -0.28±0.10 | -0.48 to -0.09 | -2.895 | 0.004 |
Changes at 6mo | -0.60±0.35 | -0.27±0.33 | -0.33±0.04 | -0.41 to -0.26 | -8.891 | 0.000 |
AL, mm | ||||||
Initial | 24.06±0.77 | 24.13±0.76 | -0.08±0.08 | -0.24 to 0.09 | -0.902 | 0.367 |
After 6mo | 24.31±0.76 | 24.32±0.76 | -0.01±0.09 | -0.17 to 0.16 | -0.105 | 0.916 |
Change at 6mo | 0.26±0.14 | 0.19±0.14 | 0.07±0.02 | 0.04 to 0.10 | 4.306 | 0.000 |
SE: Spherical equivalent; AL: Axial length; CI: Confidence interval.
mean±SD